Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
295 GBX | 0,00% | -5,75% | -16,31% |
Attività
Numero di dipendenti: 143
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell Therapy
55,3
%
| 31 | 69,0 % | 23 | 55,3 % | -25,26% |
Program-related
27,8
%
| 5 | 10,4 % | 11 | 27,8 % | +148,38% |
Drug Discovery
16,9
%
| 9 | 20,6 % | 7 | 16,9 % | -23,14% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 44 | 100,0 % | 41 | 100,0 % | -6,72% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 27/03/23 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
Corporate Officer/Principal | - | 21/08/23 | |
Gene Zhu
LAW | General Counsel | - | - |
Jill Mayer
HRO | Human Resources Officer | - | 01/01/18 |
Thomas Ross
SAM | Sales & Marketing | 63 | 15/10/14 |
Steven Nardi
PRN | Corporate Officer/Principal | - | 13/10/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 01/12/22 |
Art Mandell
BRD | Director/Board Member | 71 | 01/05/06 |
Will Brooke
BRD | Director/Board Member | 68 | 01/03/04 |
Stanley Erck
BRD | Director/Board Member | 76 | 01/01/05 |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
John Johnston
BRD | Director/Board Member | 65 | 01/01/16 |
Richard Douglas
CHM | Chairman | 71 | 12/02/18 |
Yasir Al-Wakeel
BRD | Director/Board Member | 42 | 15/06/21 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 15/06/21 |
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 104 128 650 | 97 898 738 ( 94,02 %) | 0 | 94,02 % |
Coordinate società
Settore
Vendite per attività
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-16,31% | 384 Mln | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+0,65% | 63,06 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd |
- Borsa valori
- Azioni
- Azione MXCT
- Società MaxCyte, Inc.